Page last updated: 2024-12-10

normacromerine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

normacromerine: RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3084840
SCHEMBL ID3652526
MeSH IDM0043474

Synonyms (20)

Synonym
1-(3,4-dimethoxyphenyl)-2-(methylamino)ethan-1-ol
normacromerine
1-(3,4-dimethoxyphenyl)-2-(methylamino)ethanol
AKOS009461884
FT-0673104
5653-66-7
n-methyl-3,4-dimethoxy-beta-hydroxy-beta-phenethylamine
benzenemethanol, 3,4-dimethoxy-alpha-((methylamino)methyl)-
2-(3,4-dimethoxyphenyl)-2-hydroxy-n-methylethylamine
AS-871/43475618
SCHEMBL3652526
1-(3,4-dimethoxyphenyl)-2-methylamino-ethanol
mfcd08060992
n-methyl-3,4-dimethoxyphenylethanolamine
NS-02372
1-(3,4-dimethoxyphenyl)-2-methylaminoethanol
FT-0738202
DTXSID80961983
benzenemethanol, 3,4-dimethoxy-?-[(methylamino)methyl]-
EN300-1828208
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]